Budget Estimates and officials acknowledge the slow uptake of 60-day prescriptions. The 'professionally edited' HTA review final report is with the minister, more evidence of the need to watch the diabetes tender, New Zealand's Government promises action on cancer medicines, and the need for action to ensure the legitimacy of Australia's new National Immunisation Strategy.

Latest Video
New Stories
-
Mesoblast says Ryoncil payer coverage extended to over 100 million Americans
April 22, 2025 - - Australian Biotech -
Anatara provides update following completion of analysis of Phase 2 GaRP-IBS clinical trial
April 22, 2025 - - Australian Biotech -
Recce Phase 2 trial receives additional approval for treating diabetic patients with topical gel
April 22, 2025 - - Australian Biotech -
Race says patient enrolment opened at second site for RC220 solid tumour trial
April 22, 2025 - - Australian Biotech -
Neurizon announces the appointment of chief financial officer
April 22, 2025 - - BioPharmaDispatch Executive -
Australia increasingly isolated after Europe approves Alzheimer's therapy
April 22, 2025 - - BioPharma -
Pharmac proposes three-monthly quantities for popular asthma inhalers
April 22, 2025 - - Latest News